249 related articles for article (PubMed ID: 30785037)
1. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy.
Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B
Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.
Xiao B; Viennois E; Chen Q; Wang L; Han MK; Zhang Y; Zhang Z; Kang Y; Wan Y; Merlin D
ACS Nano; 2018 Jun; 12(6):5253-5265. PubMed ID: 29860836
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of polymeric nanoparticles containing linoleic acid-SN38 (LA-SN38) conjugate in a murine model of colorectal cancer.
Cheng G; Zhang X; Chen Y; Lee RJ; Wang J; Yao J; Zhang Y; Zhang C; Wang K; Yu B
Colloids Surf B Biointerfaces; 2019 Sep; 181():822-829. PubMed ID: 31247407
[TBL] [Abstract][Full Text] [Related]
7. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.
Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery.
Smitha KT; Anitha A; Furuike T; Tamura H; Nair SV; Jayakumar R
Colloids Surf B Biointerfaces; 2013 Apr; 104():245-53. PubMed ID: 23337120
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
[TBL] [Abstract][Full Text] [Related]
10. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
Tian H; Huang Y; He J; Zhang M; Ni P
ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
[TBL] [Abstract][Full Text] [Related]
11. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
13. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
14. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
15. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
[TBL] [Abstract][Full Text] [Related]
17. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
18. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY
Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965
[TBL] [Abstract][Full Text] [Related]
20. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
